Kenvue (KVUE) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Kenvue (KVUE) do?
Kenvue Inc (KVUE) is a U.S.-listed company in Consumer Defensive (Household & Personal Products). What it does: Manufactures and markets personal care, oral care, and over-the-counter wellness products worldwide. Operates a global consumer health business spun off from Johnson & Johnson, selling iconic personal care brands. It is worth $37.09B on the market and sold $15.52B over the last year.
- Market cap
- $37.09B
- P/E ratio
- 22.0×
- Annual sales
- $15.52B
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Brief updated
- Nov 07, 2026
Brands and businesses behind KVUE
- Tylenol: Sells acetaminophen pain relief and fever reducing medicines through retail pharmacies and grocery stores.
- Neutrogena: Offers facial skincare, sun protection, and cosmetic products through mass retailers and online platforms.
- Listerine: Generates revenue from antiseptic mouthwashes and breath care products sold through supermarkets and drugstores.
- Aveeno: Produces oat-based body lotions, cleansers, and hair care items sold to global consumers.
- Band-Aid: Sells adhesive bandages and first aid wound care supplies across supermarkets and pharmacies.
- Zyrtec: Sells over-the-counter allergy relief medication to retail shoppers and pharmacy customers.
KVUE’s flags, in plain English
Each flag is a number from Kenvue’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 07, 2026.
Wide Gross Margin
Gross margin of 58.6% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Pays You to Hold
Pays a 4.33% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.
Fat Margins
Profit margin of 10.9%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.
Runway Is Short
This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about KVUE
How big is Kenvue?
Kenvue’s market cap is $37.09B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $15.52B: what customers paid the company over the last year, before any costs.
What is KVUE’s P/E ratio?
KVUE’s P/E ratio is 22.0×. Investors pay about 22.0 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with KVUE?
The company carries over seven billion dollars in long-term debt stemming from its spin-off from Johnson & Johnson. That is one risk on Kenvue’s card. Its first risk flag is Runway Is Short, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Kenvue’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. KVUE’s filings on SEC.gov. The Margin Monkey is research, not advice.
